Results of Use of WHO Global Salm-Surv External Quality Assurance System for Antimicrobial Susceptibility Testing of Salmonella Isolates from 2000 to 2007

被引:22
作者
Hendriksen, Rene S. [1 ]
Seyfarth, Anne Mette [1 ]
Jensen, Arne B. [1 ]
Whichard, Jean
Karlsmose, Susanne [1 ]
Joyce, Kevin [2 ]
Mikoleit, Matthew [2 ]
Delong, Stephanie M. [2 ]
Weill, Francois-Xavier [3 ]
Aidara-Kane, Awa [4 ]
Wong, Danilo M. A. Lo Fo [4 ]
Angulo, Frederick J. [2 ]
Wegener, Henrik C. [1 ]
Aarestrup, Frank M. [1 ]
机构
[1] Natl Food Inst, WHO Collaborating Ctr, Antimicrobial Resistance Foodborne Pathogens & Co, DK-1790 Copenhagen V, Denmark
[2] Ctr Dis Control & Prevent, Enter Dis Epidemiol Branch, WHO Collaborating Ctr Surveillance Epidemiol & Co, Atlanta, GA USA
[3] Inst Pasteur, WHO Collaborating Ctr Salmonella, Paris, France
[4] WHO, Dept Food Safety Zoonoses & Fooborne Dis, CH-1211 Geneva, Switzerland
关键词
D O I
10.1128/JCM.00894-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An international External Quality Assurance System (EQAS) for antimicrobial susceptibility testing of Salmonella was initiated in 2000 by the World Health Organization (WHO) Global Salm-Surv in order to enhance the capacities of national reference laboratories to obtain reliable data for surveillance purposes worldwide. Seven EQAS iterations have been conducted from 2000 to 2007. In each iteration, participating laboratories submitted susceptibility results from 10 to 15 antimicrobial agents for eight Salmonella isolates and an Escherichia coli reference strain (ATCC 25922). A total of 287 laboratories in 102 countries participated in at least one EQAS iteration. A large number of laboratories reported results for the E. coli ATCC 25922 reference strain which were outside the quality control ranges. Critical deviations for susceptibility testing of the Salmonella isolates varied from 4% in 2000 to 3% in 2007. Consistent difficulties were observed in susceptibility testing of amoxicillin-clavulanic acid, cefotaxime, ceftazidime, streptomycin, sulfonamides, and tetracycline. Regional variations in performance were observed, with laboratories in central Asia, Africa, and the Middle East not performing as well as those in other regions. Results from the WHO Global Salm-Surv EQAS show that most laboratories worldwide are capable of correctly performing antimicrobial susceptibility testing of Salmonella isolates, but they also indicate that further improvement for some laboratories is needed. In particular, further training and dissemination of information on quality control, appropriate interpretive criteria (breakpoints), and harmonization of the methodology worldwide through WHO Global Salm-Surv and other programs will contribute to the generation of comparable and reliable antimicrobial susceptibility data (D. M. A. Lo Fo Wong, R. S. Hendriksen, D. J. Mevius, K. T. Veldman, and F. M. Aarestrup, Vet. Microbiol. 115: 128-139, 2006).
引用
收藏
页码:79 / 85
页数:7
相关论文
共 9 条
[1]  
[Anonymous], [No title captured]
[2]  
*CLIN LAB STAND I, 2002, M31A2 NCCLS CLIN LAB
[3]  
Clinical and Laboratory Standards Institute, 2002, M100S12 NCCLS CLIN L
[4]  
Clinical and Laboratory Standards Institute, 2006, M100S16 CLIN LAB STA
[5]   Quality assurance of antimicrobial susceptibility testing by disc diffusion [J].
King, A ;
Brown, DFJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :71-76
[6]   Apparent differences in antimicrobial susceptibility as a consequence of national guidelines [J].
Leegaard, TM ;
Caugant, DA ;
Froholm, LO ;
Hoiby, EA .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (06) :290-293
[7]   External quality assurance system for antibiotic resistance in bacteria of animal origin in Europe (ARBAO-II), 2003 [J].
Lo Fo Wong, Danilo M. A. ;
Hendriksen, Rene S. ;
Mevius, Dik J. ;
Veldman, Kees T. ;
Aarestrup, Frank M. .
VETERINARY MICROBIOLOGY, 2006, 115 (1-3) :128-139
[8]   Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens [J].
Molbak, K .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (11) :1613-1620
[9]   WHO Global Salm-Surv external quality assurance system (EQAS):: An important step toward improving the quality of Salmonella serotyping and antimicrobial susceptibility testing worldwide [J].
Petersen, A ;
Aarestrup, FM ;
Angulo, FJ ;
Wong, S ;
Stöhr, K ;
Wegener, HC .
MICROBIAL DRUG RESISTANCE, 2002, 8 (04) :345-353